Insiders / Fust Matthew K / Activity
Activity — Fust Matthew K
6 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | Grant | CRNX Crinetics Pharmaceuticals, Inc. Common Stock | $0 | +6K +25.95% | 28,761 0.03% of shares | low |
| Jun 9, 2026 | Grant | ATRA Atara Biotherapeutics, Inc. Common Stock | $0 | +12K +65.98% | 30,188 0.30% of shares | low |
| May 14, 2026 | Grant | RARE Ultragenyx Pharmaceutical Inc. Common Stock | $0 | +8K +29.87% | 33,696 0.03% of shares | low |
| Jun 18, 2026 | Grant | CRNX Crinetics Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | +10K | 9,730 <0.01% of shares | low |
| May 27, 2026 | Grant | NMRA Neumora Therapeutics, Inc. Stock Option (Right to Buy) | — | +80K | 80,000 0.04% of shares | low |
| May 14, 2026 | Grant | RARE Ultragenyx Pharmaceutical Inc. Stock Option (Right to Buy) | — | +14K | 14,058 0.01% of shares | low |